Translocator protein (18 kDa): A promising therapeutic target and diagnostic tool for cardiovascular diseases

Oxidative Medicine and Cellular Longevity

Volumn , Issue , 2012, Pages

  Qi, Xiaolong ^a,b   Xu, Jiahong ^b   Wang, Fei ^b   Xiao, Junjie ^a  

^a SHANGHAI UNIVERSITY   (China)

^b TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL PROCESS; CARDIAC ELECTRICAL ACTIVITY; CARDIAC HYPERTROPHY; CARDIO-VASCULAR DISEASE; DIAGNOSTIC TOOLS; INTRACELLULAR CALCIUM; MITOCHONDRIAL ENERGY; MITOCHONDRIAL MEMBRANE POTENTIAL; MYOCARDIAL INFARCTION; PATHOLOGICAL CONDITIONS; REACTIVE OXYGEN SPECIES; RESPIRATORY CHAINS; THERAPEUTIC TARGETS; TRANS-MEMBRANE DOMAINS; TRANSLOCATORS;

ACTIVATION ANALYSIS; CARDIOVASCULAR SYSTEM; CELL DEATH; DIAGNOSTIC PRODUCTS; LIGANDS; MAGNESIUM PRINTING PLATES; MITOCHONDRIA; PROTEINS; TISSUE;

DISEASES;

MEMBRANE PROTEIN; TRANSLOCATOR PROTEIN; UNCLASSIFIED DRUG; 4 AMINOBUTYRIC ACID RECEPTOR;

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; HEART ARRHYTHMIA; HEART HYPERTROPHY; HEART INFARCTION; HUMAN; MYOCARDITIS; NONHUMAN; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; REVIEW; VASCULITIS; ANIMAL; CHEMISTRY; METABOLISM; MOLECULARLY TARGETED THERAPY;

ANIMALS; CARDIOVASCULAR DISEASES; HUMANS; MOLECULAR TARGETED THERAPY; RECEPTORS, GABA;

EID: 84871845948     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2012/162934     Document Type: Review

References (90)

1. Veenman L., Gavish M., The peripheral-type benzodiazepine receptor and the cardiovascular system. Implications for drug development. Pharmacology & Therapeutics 2006 110 3 503 524 2-s2.0-33646427447 10.1016/j.pharmthera.2005. 09.007
2. Rupprecht R., Papadopoulos V., Rammes G., Baghai T. C., Fan J., Akula N., Groyer G., Adams D., Schumacher M., Translocator protein (18 kDa) (TSPO) as a therapeutic target for neurological and psychiatric disorders. Nature Reviews Drug Discovery 2010 9 12 971 988 2-s2.0-78649687576 10.1038/nrd3295
3. Papadopoulos V., Baraldi M., Guilarte T. R., Knudsen T. B., Lacapère J. J., Lindemann P., Norenberg M. D., Nutt D., Weizman A., Zhang M. R., Gavish M., Translocator protein (18 kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function. Trends in Pharmacological Sciences 2006 27 8 402 409 2-s2.0-33746035655 10.1016/j.tips.2006.06.005 (Pubitemid 44069585)
4. Surinkaew S., Chattipakorn S., Chattipakorn N., Roles of mitochondrial benzodiazepine receptor in the heart. Canadian Journal of Cardiology 2011 27 2 262.e3 262.e13 2-s2.0-79957995104 10.1016/j.cjca.2010.12.023
5. Fan J., Lindemann P., Feuilloley M. G., Papadopoulos V., Structural and functional evolution of the translocator protein (18 kDa). Current Molecular Medicine 2012 12 4 369 386 10.2174/1566524011207040369
6. Batarseh A., Li J., Papadopoulos V., Protein kinase C ε regulation of translocator protein (18 kDa) Tspo gene expression is mediated through a MAPK pathway targeting STAT3 and c-Jun transcription factors. Biochemistry 2010 49 23 4766 4778 2-s2.0-77953283910 10.1021/bi100020e
7. Li J., Xiao J., Liang D., Zhang H., Zhang G., Liu Y., Zhang Y., Liu Y., Yu Z., Yan B., Jiang B., Li F., Peng L., Zhou Z. N., Chen Y. H., Inhibition of mitochondrial translocator protein prevents atrial fibrillation. European Journal of Pharmacology 2010 632 1-3 60 64 2-s2.0-77349102197 10.1016/j.ejphar.2010.01.014
8. Akar F. G., Aon M. A., Tomaselli G. F., O'Rourke B., The mitochondrial origin of postischemic arrhythmias. The Journal of Clinical Investigation 2005 115 12 3527 3535 2-s2.0-31044442642 10.1172/JCI25371 (Pubitemid 43121840)
9. Brown D. A., O'Rourke B., Cardiac mitochondria and arrhythmias. Cardiovascular Research 2010 88 2 241 249 2-s2.0-77956597409 10.1093/cvr/cvq231
10. Aon M. A., Cortassa S., Akar F. G., O'Rourke B., Mitochondrial criticality: a new concept at the turning point of life or death. Biochimica et Biophysica Acta 2006 1762 2 232 240 2-s2.0-29344465712 10.1016/j.bbadis.2005.06. 008 (Pubitemid 43006029)
11. Jaiswal A., Kumar S., Enjamoori R., Seth S., Dinda A. K., Maulik S. K., Peripheral benzodiazepine receptor ligand Ro5-4864 inhibits isoprenaline-induced cardiac hypertrophy in rats. European Journal of Pharmacology 2010 644 1-3 146 153 2-s2.0-77955770067 10.1016/j.ejphar.2010.06.058
12. 11C-PK11195 positron emission tomography/computed tomography. Europen Heart Journal 2012 33 15 1902 1910 10.1093/eurheartj/ehr367
13. Kindermann I., Barth C., Mahfoud F., Ukena C., Lenski M., Update on myocarditis. Journal of the American College of Cardiology 2012 59 9 779 792 10.1016/j.jacc.2011.09.074
14. Sagar S., Liu P. P., Cooper L. T. Jr., Myocarditis. The Lancet 2012 379 9817 738 747 10.1016/S0140-6736(11)60648-X
15. 11C-(R)-PK11195 PET/CT. Journal of Nuclear Medicine 2011 52 1 33 39 2-s2.0-79851482138 10.2967/jnumed.110.079038
16. Xu J., Zhao J., Evan G., Xiao C., Cheng Y., Circulating microRNAs: novel biomarkers for cardiovascular diseases. Journal of Molecular Medicine 2012 90 8 865 875 10.1007/s00109-011-0840-5
17. O'Donnell C. J., Nabel E. G., Genomics of cardiovascular disease. The New England Journal of Medicine 2011 365 2098 2109 10.1056/NEJMra1105239
18. Goldstein J. L., Brown M. S., The LDL receptor. Arteriosclerosis, Thrombosis, and Vascular Biology 2009 29 4 431 438 2-s2.0-63449102513 10.1161/ATVBAHA.108.179564
19. Baines C. P., Kaiser R. A., Sheiko T., Craigen W. J., Molkentin J. D., Voltage-dependent anion channels are dispensable for mitochondrial-dependent cell death. Nature Cell Biology 2007 9 5 550 555 2-s2.0-34247895697 10.1038/ncb1575 (Pubitemid 46696536)
20. Kokoszka J. E., Waymire K. G., Levy S. E., Sligh J. E., Cai J., Jones D. P., MacGregor G. R., Wallace D. C., The ADP/ATP translocator is not essential for the mitochondrial permeability transition pore. Nature 2004 427 6973 461 465 2-s2.0-0842307483 10.1038/nature02229 (Pubitemid 38168501)
21. Kunduzova O. R., Escourrou G., De La Farge F., Salvayre R., Séguélas M. H., Leducq N., Bono F., Herbert J. M., Parini A., Involvement of peripheral benzodiazepine receptor in the oxidative stress, death-signaling pathways, and renal injury induced by ischemia-reperfusion. Journal of the American Society of Nephrology 2004 15 8 2152 2160 2-s2.0-3543124162 10.1097/01.ASN.0000133563.41148.74 (Pubitemid 39031353)
22. Jordà E. G., Jiménez A., Verdaguer E., Canudas A. M., Folch J., Sureda F. X., Camins A., Pallàs M., Evidence in favour of a role for peripheral-type benzodiazepine receptor ligands in amplification of neuronal apoptosis. Apoptosis 2005 10 1 91 104 2-s2.0-17644383671 10.1007/s10495-005- 6064-9 (Pubitemid 40558117)
23. Betti L., Giannaccini G., Nigro M., Dianda S., Gremigni V., Lucacchini A., Studies of peripheral benzodiazepine receptors in mussels: comparison between a polluted and a nonpolluted site. Ecotoxicology and Environmental Safety 2003 54 1 36 42 2-s2.0-0037288827 10.1016/S0147-6513(02)00014-3 (Pubitemid 36263310)
24. Galiègue S., Casellas P., Kramar A., Tinel N., Simony-Lafontaine J., Immunohistochemical assessment of the peripheral benzodiazepine receptor in breast cancer and its relationship with survival. Clinical Cancer Research 2004 10 6 2058 2064 2-s2.0-1642334068 10.1158/1078-0432.CCR-03-0988 (Pubitemid 38375567)
25. Veenman L., Levin E., Weisinger G., Leschiner S., Spanier I., Snyder S. H., Weizman A., Gavish M., Peripheral-type benzodiazepine receptor density and in vitro tumorigenicity of glioma cell lines. Biochemical Pharmacology 2004 68 4 689 698 2-s2.0-3242661712 10.1016/j.bcp.2004.05.011 (Pubitemid 38953450)
26. Leducq N., Bono F., Sulpice T., Vin V., Janiak P., Le Fur G., O'Connor S. E., Herbert J. M., Role of peripheral benzodiazepine receptors in mitochondrial, cellular, and cardiac damage induced by oxidative stress and ischemia-reperfusion. Journal of Pharmacology and Experimental Therapeutics 2003 306 3 828 837 2-s2.0-0041932414 10.1124/jpet.103.052068 (Pubitemid 37025287)
27. Kletsas D., Li W., Han Z., Papadopoulos V., Peripheral-type benzodiazepine receptor (PBR) and PBR drug ligands in fibroblast and fibrosarcoma cell proliferation: role of ERK, c-Jun and ligand-activated PBR-independent pathways. Biochemical Pharmacology 2004 67 10 1927 1932 2-s2.0-2342633234 10.1016/j.bcp.2004.01.021 (Pubitemid 38591381)
28. Chen M. K., Guilarte T. R., Translocator protein 18kDa (TSPO): molecular sensor of brain injury and repair. Pharmacology & Therapeutics 2008 118 1 1 17 2-s2.0-42649115741 10.1016/j.pharmthera.2007.12.004
29. Saegusa K., Furukawa Y., Ogiwara Y., Pharmacologic basis of responses to midazolam in the isolated, cross-perfused, canine right atrium. Anesthesia and Analgesia 1987 66 8 711 718 2-s2.0-0023228234 (Pubitemid 17105066)
30. Edoute Y., Giris J., Ben-Haim S. A., Lochner A., Weizman A., Hayam G., Katz Y., Gavish M., Ro 5-4864 and PK 11195, but not diazepam, depress cardiac function in an isolated working rat heart model. Pharmacology 1993 46 4 224 230 2-s2.0-0027477402 (Pubitemid 23070493)
31. Mestre M., Carriot T., Belin C., Electrophysiological and pharmacological evidence that peripheral type benzodiazepine receptors are coupled to calcium channels in the heart. Life Sciences 1985 36 4 391 400 2-s2.0-0022005913 10.1016/0024-3205(85)90126-2 (Pubitemid 15193345)
32. Li J., Xiao J., Liu Y., Zhang G., Zhang H., Liang D., Liu Y., Zhang Y., Hu Y., Yu Z., Yan B., Jiang B., Peng L., Zhou Z. N., Chen Y. H., Mitochondrial benzodiazepine receptors mediate cardioprotection of estrogen against ischemic ventricular fibrillation. Pharmacological Research 2009 60 1 61 67 2-s2.0-67349271046 10.1016/j.phrs.2009.03.003
33. Grupp I. L., French J. F., Matlib M. A., Benzodiazepine Ro 5-4864 increases coronary flow. European Journal of Pharmacology 1987 143 1 143 147 2-s2.0-0023550173 (Pubitemid 18046815)
34. Weissman B. A., Bolger G. T., Chiang P. K., Interactions between nitrogen oxide-containing compounds and peripheral benzodiazepine receptors. FEBS Letters 1990 260 2 169 172 2-s2.0-0025124536 (Pubitemid 20042359)
35. Mestre M., Carriot T., Belin C., Electrophysiological and pharmacological characterization of peripheral benzodiazepine receptors in a guinea pig heart preparation. Life Sciences 1984 35 9 953 962 2-s2.0-0021279604 10.1016/0024-3205(84)90661-1 (Pubitemid 14100036)
36. 2+ channel. European Journal of Pharmacology 1985 118 3 293 301 2-s2.0-0022398529 10.1016/0014-2999(85)90140-2 (Pubitemid 16179854)
37. Brown D. A., Aon M. A., Akar F. G., Liu T., Sorarrain N., O'Rourke B., Effects of 4′ -chlorodiazepam on cellular excitation-contraction coupling and ischaemia-reperfusion injury in rabbit heart. Cardiovascular Research 2008 79 1 141 149 2-s2.0-45849113198 10.1093/cvr/cvn053 (Pubitemid 351881926)
38. Leeuwin R. S., Zeegers A., van Hamme J., van Wilgenburg H., Modification of cardiac actions of RO 05-4864 by PK 11195 and flumazenil in the perfused rat heart. Life Sciences 1997 61 17 1631 1642 2-s2.0-0030824560 10.1016/S0024- 3205(97)00768-6 (Pubitemid 27425284)
39. Charbonneau P., Syrota A., Crouzel C., Peripheral-type benzodiazepine receptors in the living heart characterized by positron emission tomography. Circulation 1986 73 3 476 483 2-s2.0-0022578611 (Pubitemid 16133026)
40. James M. L., Selleri S., Kassiou M., Development of ligands for the peripheral benzodiazepine receptor. Current Medicinal Chemistry 2006 13 17 1991 2001 2-s2.0-33745745762 10.2174/092986706777584979
41. Banati R. B., Visualising microglial activation in vivo. Glia 2002 40 2 206 217 2-s2.0-0036850086 10.1002/glia.10144 (Pubitemid 35337378)
42. Schaller S., Paradis S., Ngoh G. A., Assaly R., Buisson B., Drouot C., Ostuni M. A., Lacapere J. J., Bassissi F., Bordet T., Berdeaux A., Jones S. P., Morin D., Pruss R. M., TRO40303, a new cardioprotective compound, inhibits mitochondrial permeability transition. Journal of Pharmacology and Experimental Therapeutics 2010 333 3 696 706 2-s2.0-77952368170 10.1124/jpet.110.167486
43. Aon M. A., Cortassa S., Akar F. G., Brown D. A., Zhou L., O'Rourke B., From mitochondrial dynamics to arrhythmias. The International Journal of Biochemistry & Cell Biology 2009 41 10 1940 1948 2-s2.0-68949132677 10.1016/j.biocel.2009.02.016
44. Schmidt C., Kisselbach J., Schweizer P. A., Katus H. A., Thomas D., The pathology and treatment of cardiac arrhythmias: focus on atrial fibrillation. Vascular Health and Risk Management 2011 7 193 202 2-s2.0-79961187513
45. Wann L. S., Curtis A. B., January C. T., Ellenbogen K. A., Lowe J. E., Estes N. A. M., Page R. L., Ezekowitz M. D., Slotwiner D. J., Jackman W. M., Stevenson W. G., Tracy C. M., 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (updating the 2006 guideline): a report of the American college of cardiology foundation/American heart association task force on practice guidelines. Circulation 2011 123 1 104 123 2-s2.0-78751623197 10.1161/CIR.0b013e3181fa3cf4
46. Li J., Xu J., Xiao J., Zhang H., Liang D., Liu Y., Zhang Y., Liu Y., Wen W., Hu Y., Yu Z., Yan B., Jiang B., Zhou Z. N., Chen Y. H., Preservation of TSPO by chronic intermittent hypobaric hypoxia confers antiarrhythmic activity. Journal of Cellular and Molecular Medicine 2011 15 1 134 140 2-s2.0-78751682409 10.1111/j.1582-4934.2009.00949.x
47. Brady N. R., Hamacher-Brady A., Westerhoff H. V., Gottlieb R. A., A wave of reactive oxygen species (ROS)-induced ROS release in a sea of excitable mitochondria. Antioxidants and Redox Signaling 2006 8 9-10 1651 1665 2-s2.0-33750920827 10.1089/ars.2006.8.1651 (Pubitemid 44726339)
48. Zorov D. B., Juhaszova M., Sollott S. J., Mitochondrial ROS-induced ROS release: an update and review. Biochimica et Biophysica Acta 2006 1757 5-6 509 517 2-s2.0-33745684904 10.1016/j.bbabio.2006.04.029
49. Cho J., Won K., Wu D., Soong Y., Liu S., Szeto H. H., Hong M. K., Potent mitochondria-targeted peptides reduce myocardial infarction in rats. Coronary Artery Disease 2007 18 3 215 220 2-s2.0-34247209532 10.1097/01.mca.0000236285. 71683.b6 (Pubitemid 46608500)
50. Aon M. A., Cortassa S., Maack C., O'Rourke B., Sequential opening of mitochondrial ion channels as a function of glutathione redox thiol status. The Journal of Biological Chemistry 2007 282 30 21889 21900 2-s2.0-34547578624 10.1074/jbc.M702841200 (Pubitemid 47195754)
51. Aon M. A., Cortassa S., Marbán E., O'Rourke B., Synchronized whole cell oscillations in mitochondrial metabolism triggered by a local release of reactive oxygen species in cardiac myocytes. The Journal of Biological Chemistry 2003 278 45 44735 44744 2-s2.0-0242582202 10.1074/jbc.M302673200 (Pubitemid 37377231)
52. Aon M. A., Cortassa S., O'Rourke B., Mitochondrial oscillations in physiology and pathophysiology. Advances in Experimental Medicine and Biology 2008 641 98 117 2-s2.0-55949103543 10.1007/978-0-387-09794-7-8
53. Brown D. A., Aon M. A., Frasier C. R., Sloan R. C., Maloney A. H., Anderson E. J., O'Rourke B., Cardiac arrhythmias induced by glutathione oxidation can be inhibited by preventing mitochondrial depolarization. Journal of Molecular and Cellular Cardiology 2010 48 4 673 679 2-s2.0-77649271619 10.1016/j.yjmcc.2009.11.011
54. Piot C., Croisille P., Staat P., Thibault H., Rioufol G., Mewton N., Elbelghiti R., Thien T. C., Bonnefoy E., Angoulvant D., Macia C., Raczka F., Sportouch C., Gahide G., Finet G., André-Fouët X., Revel D., Kirkorian G., Monassier J. P., Derumeaux G., Ovize M., Effect of cyclosporine on reperfusion injury in acute myocardial infarction. The New England Journal of Medicine 2008 359 5 473 481 2-s2.0-48249109117 10.1056/NEJMoa071142
55. Billman G. E., The cardiac sarcolemmal ATP-sensitive potassium channel as a novel target for anti-arrhythmic therapy. Pharmacology & Therapeutics 2008 120 1 54 70 2-s2.0-51849154149 10.1016/j.pharmthera.2008.07.004
56. Dongó E., Hornyák I., Benko Z., Kiss L., The cardioprotective potential of hydrogen sulfide in myocardial ischemia/reperfusion injury. Acta Physiologica Hungarica 2011 98 4 369 381 10.1556/APhysiol.98.2011.4.1
57. Liem D. A., Honda H. M., Zhang J., Woo D., Ping P., Past and present course of cardioprotection against ischemia-reperfusion injury. Journal of Applied Physiology 2007 103 6 2129 2136 2-s2.0-36849061044 10.1152/japplphysiol. 00383.2007 (Pubitemid 350232399)
58. Ferdinandy P., Schulz R., Baxter G. F., Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning. Pharmacological Reviews 2007 59 4 418 458 2-s2.0-37549038706 10.1124/pr.107.06002
59. Halestrap A. P., What is the mitochondrial permeability transition pore? Journal of Molecular and Cellular Cardiology 2009 46 6 821 831 2-s2.0-67349117275 10.1016/j.yjmcc.2009.02.021
60. Ricchelli F., Šileikyte J., Bernardi P., Shedding light on the mitochondrial permeability transition. Biochimica et Biophysica Acta 2011 1807 5 482 490 2-s2.0-79952992069 10.1016/j.bbabio.2011.02.012
61. Argaud L., Gateau-Roesch O., Muntean D., Chalabreysse L., Loufouat J., Robert D., Ovize M., Specific inhibition of the mitochondrial permeability transition prevents lethal reperfusion injury. Journal of Molecular and Cellular Cardiology 2005 38 2 367 374 2-s2.0-13444282326 10.1016/j.yjmcc.2004.12.001 (Pubitemid 40215206)
62. Oka N., Wang L., Mi W., Zhu W., Honjo O., Caldarone C. A., Cyclosporine A prevents apoptosis-related mitochondrial dysfunction after neonatal cardioplegic arrest. The Journal of Thoracic and Cardiovascular Surgery 2008 135 1 123.e2 130.e2 2-s2.0-37549033459 10.1016/j.jtcvs.2007.05.009
63. Šileikyte J., Petronilli V., Zulian A., Dabbeni-Sala F., Tognon G., Nikolov P., Bernardi P., Ricchelli F., Regulation of the inner membrane mitochondrial permeability transition by the outer membrane translocator protein (peripheral benzodiazepine receptor). The Journal of Biological Chemistry 2011 286 2 1046 1053 2-s2.0-78651385379 10.1074/jbc.M110.172486
64. Xiao J., Liang D., Zhang H., Liu Y., Li F., Chen Y. H., 4 ′ -chlorodiazepam, a translocator protein (18 kDa) antagonist, improves cardiac functional recovery during postischemia reperfusion in rats. Experimental Biology and Medicine 2010 235 4 478 486 2-s2.0-77951646609 10.1258/ebm.2009. 009291
65. Obame F. N., Zini R., Souktani R., Berdeaux A., Morin D., Peripheral benzodiazepine receptor-induced myocardial protection is mediated by inhibition of mitochondrial membrane permeabilization. Journal of Pharmacology and Experimental Therapeutics 2007 323 1 336 345 2-s2.0-34548861265 10.1124/jpet.107.124255 (Pubitemid 47443246)
66. Maulik S. K., Kumar S., Oxidative stress and cardiac hypertrophy: a review. Toxicology Mechanisms Methods 2012 22 359 366 10.3109/15376516.2012. 666650
67. Ainscough J. F. X., Drinkhill M. J., Sedo A., Turner N. A., Brooke D. A., Balmforth A. J., Ball S. G., Angiotensin II type-1 receptor activation in the adult heart causes blood pressure-independent hypertrophy and cardiac dysfunction. Cardiovascular Research 2009 81 3 592 600 2-s2.0-59449109185 10.1093/cvr/cvn230
68. Gupta M. P., Factors controlling cardiac myosin-isoform shift during hypertrophy and heart failure. Journal of Molecular and Cellular Cardiology 2007 43 4 388 403 2-s2.0-34748888492 10.1016/j.yjmcc.2007.07.045 (Pubitemid 47469981)
69. Tsutsui H., Kinugawa S., Matsushima S., Mitochondrial oxidative stress and dysfunction in myocardial remodelling. Cardiovascular Research 2009 81 3 449 456 2-s2.0-59449104627 10.1093/cvr/cvn280
70. Badenhorst D., Veliotes D., Maseko M., Tsotetsi O. J., Brooksbank R., Naidoo A., Woodiwiss A. J., Norton G. R., β -adrenergic activation initiates chamber dilatation in concentric hypertrophy. Hypertension 2003 41 3 499 504 2-s2.0-0037336833 10.1161/01.HYP.0000056601.29613.DD (Pubitemid 36314623)
71. van Vré E. A., van Brussel I., Bosmans J. M., Dendritic cells in human atherosclerosis: from circulation to atherosclerotic plaques. Mediators of Inflammation 2011 2011 13 941396 10.1155/2011/941396
72. Thorp E., Subramanian M., Tabas I., The role of macrophages and dendritic cells in the clearance of apoptotic cells in advanced atherosclerosis. European Journal of Immunology 2011 41 9 2515 2518 10.1002/eji.201141719
73. 3H]PK 11195. Atherosclerosis 2008 201 1 108 111 2-s2.0-53849125027 10.1016/j.atherosclerosis.2008.02.032
74. Park J. G., Oh G. T., The role of peroxidases in the pathogenesis of atherosclerosis. BMB Reports 2011 44 8 497 505 10.5483/BMBRep.2011.44.8.497
75. Bird J. L. E., Izquierdo-Garcia D., Davies J. R., Rudd J. H. F., Probst K. C., Figg N., Clark J. C., Weissberg P. L., Davenport A. P., Warburton E. A., Evaluation of translocator protein quantification as a tool for characterising macrophage burden in human carotid atherosclerosis. Atherosclerosis 2010 210 2 388 391 2-s2.0-77953230719 10.1016/j.atherosclerosis.2009.11.047
76. 11C]PK11195 into mouse atherosclerotic plaques. European Journal of Nuclear Medicine and Molecular Imaging 2009 36 1 73 80 2-s2.0-57249097213 10.1007/s00259-008-0919-6
77. Dimitrova-Shumkovska J., Veenman L., Ristoski T., Leschiner S., Gavish M., Chronic high fat, high cholesterol supplementation decreases 18 kDa translocator protein binding capacity in association with increased oxidative stress in rat liver and aorta. Food and Chemical Toxicology 2010 48 3 910 921 2-s2.0-77049124222 10.1016/j.fct.2009.12.032
78. Fatkin D., members of the CSANZ Cardiac Genetic Diseases Council Writing Group, Guidelines for the diagnosis and management of familial dilated cardiomyopathy. Heart, Lung and Circulation 2011 20 11 691 693
79. Movsesian M., Wever-Pinzon O., Vandeput F., PDE3 inhibition in dilated cardiomyopathy. Current Opinion in Pharmacology 2011 11 6 707 713 10.1016/j.coph.2011.09.001
80. Fabre A., Sheppard M. N., Sudden adult death syndrome and other non-ischaemic causes of sudden cardiac death. Heart 2006 92 3 316 320 2-s2.0-33644560307 10.1136/hrt.2004.045518
81. Onyimba J. A., Coronado M. J., Garton A. E., Kim J. B., Bucek A., The innate immune response to coxsackievirus B3 predicts progression to cardiovascular disease and heart failure in male mice. Biology of Sex Differences 2011 2, article 2 10.1186/2042-6410-2-2
82. Frisancho-Kiss S., Davis S. E., Nyland J. F., Frisancho J. A., Cihakova D., Barrett M. A., Rose N. R., Fairweather D., Cutting edge: cross-regulation by TLR4 and T cell Ig mucin-3 determines sex differences in inflammatory heart disease. The Journal of Immunology 2007 178 11 6710 6714 2-s2.0-34249811203 (Pubitemid 46847392)
83. Pipitone N., Versari A., Salvarani C., Role of imaging studies in the diagnosis and follow-up of large-vessel vasculitis: an update. Rheumatology 2008 47 4 403 408 2-s2.0-43049178437 10.1093/rheumatology/kem379
84. Gulati A., Bagga A., Large vessel vasculitis. Pediatric Nephrology 2010 25 6 1037 1048 2-s2.0-77951253595 10.1007/s00467-009-1312-9
85. Caspary L., Schellong S., Large vessel vasculitis. Der Internist 2009 50 8 958 963 2-s2.0-68549125079 10.1007/s00108-009-2363-5
86. Sano K., Takayasu disease-pulseless disease. Brain and Nerve 2008 60 1 31 35 2-s2.0-38749128435 (Pubitemid 351185102)
87. 11C](R)- PK11195 PET study. NeuroImage 2005 24 2 591 595 2-s2.0-16244422002 10.1016/j.neuroimage.2004.09.034 (Pubitemid 41359057)
88. 11C]PK11195 positron emission tomography study. Biological Psychiatry 2008 64 9 820 822 2-s2.0-53249144430 10.1016/j.biopsych.2008.04.025
89. 11C]-PK11195 and positron emission tomography/computed tomography angiography. Journal of the American College of Cardiology 2010 56 8 653 661 2-s2.0-77955689702 10.1016/j.jacc.2010.02.063
90. 3H]PK 11195. Atherosclerosis 2008 201 1 108 111 2-s2.0-53849125027 10.1016/j.atherosclerosis.2008.02.032